204 related articles for article (PubMed ID: 37940999)
1. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
[TBL] [Abstract][Full Text] [Related]
2. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.
Araya J; Tsubouchi K; Sato N; Ito S; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Yoshida M; Fujita Y; Utsumi H; Kobayashi K; Yanagisawa H; Hashimoto M; Wakui H; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nishimura SL; Nakayama K; Kuwano K
Autophagy; 2019 Mar; 15(3):510-526. PubMed ID: 30290714
[TBL] [Abstract][Full Text] [Related]
3. MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway.
Liu J; Zhang J; Zhang Y; Yang B; Liu H; Chen Y
Funct Integr Genomics; 2024 Apr; 24(2):71. PubMed ID: 38568332
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
6. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
7. ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity.
Ali R; Alabdullah M; Miligy I; Normatova M; Babaei-Jadidi R; Nateri AS; Rakha EA; Madhusudan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31635307
[TBL] [Abstract][Full Text] [Related]
8. WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice.
Li H; Zhang P; Zhang Q; Li C; Zou W; Chang Z; Cui CP; Zhang L
J Biol Chem; 2018 Jun; 293(23):8886-8899. PubMed ID: 29685889
[TBL] [Abstract][Full Text] [Related]
9. PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1-Parkin-mediated mitophagy.
Wang L; Cho YL; Tang Y; Wang J; Park JE; Wu Y; Wang C; Tong Y; Chawla R; Zhang J; Shi Y; Deng S; Lu G; Wu Y; Tan HW; Pawijit P; Lim GG; Chan HY; Zhang J; Fang L; Yu H; Liou YC; Karthik M; Bay BH; Lim KL; Sze SK; Yap CT; Shen HM
Cell Res; 2018 Aug; 28(8):787-802. PubMed ID: 29934616
[TBL] [Abstract][Full Text] [Related]
10. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
12. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
13.
Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
[TBL] [Abstract][Full Text] [Related]
14. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
[TBL] [Abstract][Full Text] [Related]
16. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
17. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance.
Singh M; Chaudhry P; Fabi F; Asselin E
BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432
[TBL] [Abstract][Full Text] [Related]
20. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
